Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FAAH | O00519 | 2/20 | 0.33 |
| ▸ | MGLL | Q99685 | 2/20 | 0.33 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.33 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.33 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.33 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.33 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22983608 | 0.93 | FAAH (0.37) | FAAHMGLLSMN1; SMN2KMT2A | |
| SCHEMBL8539509 | 0.81 | — | — | |
| SCHEMBL15320203 | 0.78 | MGLL (0.40) | FAAHMGLL | |
| SCHEMBL15067131 | 0.77 | CHRM2 (0.31) | CHRM2CHRM4CHRM5CHRM1CHRM3 | |
| SCHEMBL21360131 | 0.76 | FAAH (0.36) | FAAHMGLLCHRM2CHRM4CHRM5 | |
| SCHEMBL21033765 | 0.75 | FAAH (0.35) | FAAHMGLLCHRM2CHRM4CHRM5 | |
| SCHEMBL9818026 | 0.73 | FAAH (0.37) | FAAHMGLLSMN1; SMN2TSHRKMT2A | |
| SCHEMBL1982533 | 0.71 | FAAH (0.39) | FAAHMGLLSMN1; SMN2KMT2A | |
| SCHEMBL21575529 | 0.69 | MGLL (0.41) | FAAHMGLLSMN1; SMN2KMT2A | |
| SCHEMBL21648859 | 0.69 | MGLL (0.41) | FAAHMGLLSMN1; SMN2KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0329994-B1 | Immunogen and its use in preparing antibodies to haemoglobin A1C | BOEHRINGER MANNHEIM GMBH (DE) | 1993-12-29 | — | — | EP | claimed |
| CN-117580593-A | Anthracycline antibody conjugates | 思进公司 | 2024-02-20 | — | — | CN | disclosed |
| CN-116847886-A | Immunostimulatory compounds and conjugates | 思进公司 | 2023-10-03 | — | — | CN | disclosed |
| CN-116829551-A | Immunomodulatory antibody drug conjugates | 思进公司 | 2023-09-29 | — | — | CN | disclosed |
| CN-115955980-A | Variable charge joint | 思进公司 | 2023-04-11 | — | — | CN | disclosed |
| US-5646255-A | REACTION PRODUCT OF PROTEIN, SUCCINIMIDE DERIVATIVE AND TETRAPEPTIDE SEQUENCE OF VALINE-HISTIDINE-LEUCINE-THREONINE | BOEHRINGER MANNHEIM GMBH (DE) | 1997-07-08 | — | — | US | disclosed |
| US-5632993-A | DIABETES DIAGNOSIS | BOEHRINGER MANNHEIM GMBH (DE) | 1997-05-27 | — | — | US | disclosed |
| EP-0329994-A1 | Immunogen and its use in preparing antibodies to haemoglobin A1C | Roche Diagnostics GmbH (DE) | 1989-08-30 | — | — | EP | disclosed |